Chiral analytical method development of liquiritigenin with application to a pharmacokinetic study
- 20 July 2012
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 27 (3) , 404-406
Abstract
Pharmacometric characterization studies of liquiritigenin have historically overlooked its chiral nature. To achieve complete characterization, an analytical method enabling the detection and quantification of the individual enantiomers of racemic (±) liquiritigenin is necessary. Resolution of the enantiomers of liquiritigenin was achieved using a simple high‐performance liquid chromatographic method. A Chiralpak® ADRH column was employed to perform baseline separation with UV detection at 210 nm.The standard curves were linear ranging from 0.5 to 100 µg/mL for each enantiomer. Limit of quantification was 0.5 µg/mL. The assay was applied successfully to stereoselective serum disposition of liquiritigenin enantiomers in rats. Liquiritigenin enantiomers were detected in serum as both aglycones and glucuronidated conjugates. Both unconjugated enantiomers had a serum half‐life of ~15 min in rats. The volume of distribution (Vd) for S‐ and R‐liquiritigenin was 1.49 and 2.21 L/kg, respectively. Total clearance (Cltotal) was 5.12 L/h/kg for S‐liquiritigenin and 4.79 L/h/kg for R‐liquiritigenin, and area under the curve (AUC0‐inf) was 3.95 µg h/mL for S‐liquiritigenin and 4.23 µg h/mL for R‐liquiritigenin. The large volume of distribution coupled with the short serum half‐life suggests extensive distribution of liquiritigenin into tissues. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 13 references indexed in Scilit:
- Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in RodentsCurrent Neuropharmacology, 2011
- Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5′-diphosphoglucuronic acid levelMetabolism, 2010
- Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced byd-galactosamine/lipopolysaccharide or CCl4Xenobiotica, 2010
- Pharmacokinetics of Liquiritigenin in Mice, Rats, Rabbits, and Dogs, and Animal Scale-UpJournal of Pharmaceutical Sciences, 2009
- Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effectXenobiotica, 2009
- Effect of liquiritigenin, a flavanone existed from Radix glycyrrhizae on pro-apoptotic in SMMC-7721 cellsFood and Chemical Toxicology, 2009
- Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Liquiritigenin is a plant-derived highly selective estrogen receptor β agonistMolecular and Cellular Endocrinology, 2008
- Simultaneous quantification of multiple licorice flavonoids in rat plasmaJournal of the American Society for Mass Spectrometry, 2007
- Chiral resolution of four major flavanones in post-administrative urine of chinese herbal medicines by HPLC on macroporous silica gel coated with cellulose tris(3,5-dimethylphenylcarbamate)Biomedical Chromatography, 1998